Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHR1S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,879
Award facts
- Contract value 100% obligated
- $18,879.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,879.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The award was issued on January 14, 2026, with an ultimate completion date of January 15, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Zepbound reflects the contractor's ongoing role in supplying essential pharmaceutical commodities to support military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FHR1S?
SPE2DR26FHR1S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FHR1S worth?
The government has obligated $18,879 on SPE2DR26FHR1S.
Is contract SPE2DR26FHR1S an order under another contract?
Yes. SPE2DR26FHR1S is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHR1S competed?
The extent of competition for SPE2DR26FHR1S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award